NSC |
Compound |
Enrichment |
Correlation |
NSC 714187 |
3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate |
0.0181211508101519 |
0.41508631 |
NSC 733465 |
Null |
0.0181211508101519 |
0.095969975 |
NSC 742256 |
8-(4-Amino-1-methylbutyl)amino-2-methyl-5,6-dihydroxyquinoline, 2.3-hydrobromide, 0.8 hydrate |
0.0181211508101519 |
0.11607979 |
NSC 743853 |
Null |
0.0181211508101519 |
0.17285104 |
NSC 92915 |
ANTINEOPLASTIC-92915 |
0.0181211508101519 |
0.1442862 |
NSC 104801 |
Cytembena |
0.0208632511155816 |
0.18163093 |
NSC 132791 |
Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo |
0.0208632511155816 |
0.33885947 |
NSC 374980 |
Acetamide, N-[2,3-bis(acetyloxy)-5,6,7,9-tetrahydro-1-methoxy-10-(methylthio)-9-oxobenzo[a]heptalen-7-yl]-, (S)- |
0.0208632511155817 |
0.2523112 |
NSC 375162 |
Imidazo[1,2-a]pyridine-6-carboxaldehyde, 2-[4-[[(4,5-dihydro-1H-imidazol-2-yl)hydrazono]methyl]phenyl]-, (4,5-dihydro-1H-imidazol-2-yl)hydrazone, dihydroiodide |
0.0208632511155817 |
0.22596225 |
NSC 375726 |
BACCHARINOID A-1 (BUSAM) |
0.0208632511155817 |
0.40666076 |